Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET ® CC-96191.

Autor: Lunn-Halbert, Margaret C.1 (AUTHOR), Laszlo, George S.1 (AUTHOR), Erraiss, Sarah1 (AUTHOR), Orr, Mark T.2 (AUTHOR), Jessup, Heidi K.2 (AUTHOR), Thomas, Heather J.2 (AUTHOR), Chan, Henry3 (AUTHOR), Jahromi, Mahan A.3 (AUTHOR), Lloyd, Jonathan3 (AUTHOR), Cheung, Ann F.4 (AUTHOR), Chang, Gregory P.4 (AUTHOR), Dichwalkar, Tanmay4 (AUTHOR), Fallon, Daniel4 (AUTHOR), Grinberg, Asya4 (AUTHOR), Rodríguez-Arbolí, Eduardo1,5 (AUTHOR), Lim, Sheryl Y. T.1 (AUTHOR), Kehret, Allie R.1 (AUTHOR), Huo, Jenny1 (AUTHOR), Cole, Frances M.1 (AUTHOR), Scharffenberger, Samuel C.6 (AUTHOR)
Zdroj: Cancers. Mar2024, Vol. 16 Issue 5, p877. 17p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje